Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Glycolic acid + salicylic acid is a topical combination of two exfoliating agents commonly used in dermatology for the treatment of mild to moderate acne, rosacea, folliculitis, keratosis pilaris, and other skin conditions characterized by clogged pores or uneven texture. Glycolic acid is an alpha-hydroxy acid (AHA) that works on the surface of the skin to dissolve dead skin cells and promote gentle exfoliation. Salicylic acid is a beta-hydroxy acid (BHA) that penetrates deep into pores to remove sebum and debris while also providing anti-inflammatory effects. Together, this combination offers both surface-level and pore-deep exfoliation for improved skin clarity and texture. Clinical studies have shown significant improvement in acne lesions with this combination compared to standard treatments[1][2][4][9]. The mechanism involves desquamation (shedding) of corneocytes by glycolic acid and comedolytic action by salicylic acid.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on glycolic acid + salicylic acid.